Serbian Biomarker Symposium

SERBIS 2020

7th Serbian Biomarker Symposium

Biomarkers of gastrointestinal diseases

April

 

 

Day Two.

 

THURSDAY, April 08th, 2020 Postponed

 

Room Atlantic/Pacific

 

 

 

Session 6

Chairs: Miodrag KRSTIC, Tamara MILOVANOVIC

 

09:00-09:20

NAFD: a multi-system disease

Prof. Miodrag KRSTIC, Serbia

 

09:20-09:40

Biomarkers in nonalcoholic fatty liver  disease

Prof. Tamara MILOVANOVIC, Serbia

 

09:40-10:00

Clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of chronic liver disease.

Prof. William ROSENBERG, UK

 

10:00-10:10

Non-invasive assesment of liver disease, where is the place of ELF score?

Asst. dr Vladimir MILIVOJEVIC, Serbia

 

10:10-10:25

ELF test and alcohol abuse

Asst. Prof. Ivica AVBERSEK-LUZNIK, Slovenia

 

10:25-10:45

From steatosis to liver cancer development: Is there a place for biomarkers?

Asst. Prof. Danijel GALUN, Serbia

 

10:45-11:05

Hepatocellular carcinoma biomarkers: focus on glypican-3

Dr Gian Paolo CAVIGLIA, Italy

 

11:05-11:20

Q&A (Discussion)

 

11:20-11:50

Workshop

 

 

 

Session 7

Chairs: Milos BJELOVIC, Milica LALOSEVIC STOJKOVIC

 

11:50-12:10

Laboratory diagnosis of acute pancreatitis

Prof. Mauro PANTEGHINI, Italy

 

12:10-12:30

Current trends in gastric cancer treatment

Prof. Milos BJELOVIC, Serbia

 

12:30-12:50

The expanding role of molecular biomarkers and immunotherapy in noncolorectal GI cancers

Dr Nenad MIJALKOVIC, Serbia

 

12:50-13:05

CEACAMs and gastrointestinal cancer

Snezana GOLUBOVIC, Serbia

 

13:05-13:25

Colorectal cancer, what future may bring us: focus on biomarkers

Asst. dr Milica LALOSEVIC STOJKOVIC, Serbia

 

13:25-13:40

Tumor M2-pyruvate kinase: biomarker for pancreatic and colorectal cancer?

Asst. Prof. Sanja STANKOVIC, Serbia

 

13:40-14:00

Molecular-genetic stool analyses in everyday laboratory practice

Dr. Ingmar ZUDE, Germany

 

14:00-14:15

Q&A (Discussion)

 

 

 

Session 8

Chairs: Ingolf CASCORBI, Ognjan SKROBIC

 

14:15-14:30

Bariatric surgery in obesity

Asst. dr Ognjan SKROBIC, Serbia

 

14:30-14:50

mRNA and microRNA adaptation processes after Roux-en-Y gastric bypass in obese patients

Prof. Ingolf CASCORBI, Germany

 

14:50-15:00

Q&A (Discussion)

 

15:00-15:30

SERBIS Awards

 

15:30-16:00

Lunch break

 

 

 

Session 9

 

16:00-17:00

Pharmacogentic corner

ESPT Board Members

 

Pharmacogenetics of gastrointestinal disease

 

Pharmacogenetics of gastrointestinal bleeding

 

Pharmacogenetic implementation in clinical practice based on e-health for Public Health Service (MedeA)

 

Genome approach to chronic diseases

 

Prof. Ron VAN SCHAIK, The Netherlands

Asst. Prof. Csilla SIPEKY, Finland

Prof. Janja MARC, Slovenia

Prof. Adrián LLERENA, Spain

Prof. Ingolf CASCORBI, Germany

Prof. Maurizzio SIMACO, Italy

Asst. Prof. Sanja STANKOVIC, Serbia

 

17:00-17:15

Closing remarks

 

 

 

Serbis Timeline >

 

 

 

 

Under the auspices of